RCUS · Arcus Biosciences, Inc.

Summary

On March 17, 2026, Jennifer Jarrett notified Arcus Biosciences, Inc. of her resignation as Chief Operating Officer, effective March 30, 2026, not due to any disagreement with the Company. The Company entered a separation agreement providing for her periodic advisory services through June 30, 2026, extension of post-termination vested option exercise period to 12 months, and a standard release of claims.

Key takeaways

• Jennifer Jarrett resigns as Chief Operating Officer effective 2026-03-30
• Resignation not due to disagreement on operations, policies, or practices
• Advisory services through 2026-06-30
• Post-termination vested options exercisable for 12 months
• Separation agreement includes standard release of claims